Skip to main content

Series A Biotechnology Companies

Explore 772 biotechnology startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
772
Total Funding
$682.8M
Avg Funding
$27.3M
Cities
22

Export 772 Series A Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Stockholm, Sweden
$7.3M
raised

Pixelgen Technologies develops technologies for biomedical research and diagnostics.

Oct 2023
Series A

Founder Contacts

30,000+ verified contacts

Berkeley, United States
$9.5M
raised

Pow.bio provides a genetically engineered solution for fermentation scientists.

Oct 2023
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom
$10.0M
raised

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Oct 2023
Series A

Founder Contacts

30,000+ verified contacts

Lausanne, Switzerland
$13.6M
raised

Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Plymouth Meeting, United States
$5.0M
raised

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$14.0M
raised

Evvy develops at-home vaginal microbiome tests using metagenomic sequencing to understand symptoms and risks for critical health challenges.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Hamburg, Germany
$38.8M
raised

traceless materials is a circular bioeconomy startup offering a holistically sustainable alternative to conventional plastics & bioplastics

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Zúrich, Switzerland
$37.9M
raised

TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Rue Du Rosult, France
$10.7M
raised

Stane's objective is to mobilize collective wisdom to improve community medicine's performance.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$50.0M
raised

Magnet Biomedicine is a biotechnology research platform specializing in discovering true molecular glues.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United Kingdom
$15.0M
raised

Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Nantes, France
$29.2M
raised

AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Newhouse, United Kingdom
$38.3M
raised

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

$69.5M
raised

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Palo Alto, United States
$100.0M
raised

Inceptive designs RNA molecules using large-scale deep learning in a tight loop with high-throughput experiments.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Atlanta, United States
$7.0M
raised

Lucid Scientific is a biotechnology company that designs and develops a series of real-time cellular activity monitors.

Sep 2023
Series A

Founder Contacts

30,000+ verified contacts

Allston, United States
$46.0M
raised

I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.

Aug 2023
Series A

Founder Contacts

30,000+ verified contacts

Boston, United States

Pear Bio is an AI-enabled biotech company focused on patient-centered cancer precision medicine

Aug 2023
Series A

Founder Contacts

30,000+ verified contacts

Sunnyvale, United States
$1.1M
raised

QuantumCyte is a technology platform company developing automated microdissection solutions for molecular pathology.

Aug 2023
Series A

Founder Contacts

30,000+ verified contacts

Gaithersburg, United States
$75.0M
raised

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

Aug 2023
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Singapore, Singapore
$15.0M
raised

Allozymes is a biotech company that accelerating enzyme evolution for the sustainable future of industries

Aug 2023
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$20.0M
raised

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

Aug 2023
Series A

Founder Contacts

30,000+ verified contacts

Millbrae, United States

Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.

Jul 2023
Series A

Founder Contacts

30,000+ verified contacts

Littleton, United States
$60.0M
raised

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.

Jul 2023
Series A

Founder Contacts

30,000+ verified contacts

Baltimore, United States
$10.0M
raised

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

Jul 2023
Series A

Founder Contacts

30,000+ verified contacts

Showing 501 to 525 of 772 companies

Ready to Connect with Series A Biotechnology Startups?

Get verified founder emails, funding details, and company data for 772 series a biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked